Pages that link to "Q26850196"
Jump to navigation
Jump to search
The following pages link to A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation (Q26850196):
Displaying 50 items.
- Echocardiography in shock management (Q26740265) (← links)
- Adiponectin resistance in skeletal muscle: pathophysiological implications in chronic heart failure (Q26745026) (← links)
- Heart Failure: Diagnosis, Management and Utilization (Q26745543) (← links)
- A clinical approach to obstructive sleep apnea as a risk factor for cardiovascular disease (Q26751303) (← links)
- Targeting heart failure with preserved ejection fraction: current status and future prospects (Q26752956) (← links)
- The role of titin and extracellular matrix remodelling in heart failure with preserved ejection fraction (Q26765101) (← links)
- Is enhancing cGMP-PKG signalling a promising therapeutic target for heart failure with preserved ejection fraction? (Q26765931) (← links)
- Improved Cardiovascular Disease Outcomes in Older Adults (Q26766094) (← links)
- Understanding heart failure with preserved ejection fraction: where are we today? (Q26766590) (← links)
- Uncovering heart failure with preserved ejection fraction in patients with type 2 diabetes in primary care: time for a change (Q26767122) (← links)
- Breakthrough in heart failure with preserved ejection fraction: are we there yet? (Q26771999) (← links)
- Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy (Q26775037) (← links)
- Reporting trends of randomised controlled trials in heart failure with preserved ejection fraction: a systematic review (Q26779538) (← links)
- Challenging aspects of treatment strategies in heart failure with preserved ejection fraction: "Why did recent clinical trials fail?" (Q26785931) (← links)
- Myocardial hypertrophy and its role in heart failure with preserved ejection fraction (Q26800076) (← links)
- Heart failure and Alzheimer's disease (Q26852526) (← links)
- Cardiac endothelium-myocyte interaction: clinical opportunities for new heart failure therapies regardless of ejection fraction (Q26853363) (← links)
- Exercise intolerance in heart failure with preserved ejection fraction: more than a heart problem (Q26991985) (← links)
- Heart failure with preserved ejection fraction: mechanisms, clinical features, and therapies (Q27000263) (← links)
- Patient selection in heart failure with preserved ejection fraction clinical trials (Q27015845) (← links)
- Heart failure with preserved ejection fraction (Q27024008) (← links)
- The cGMP signaling pathway as a therapeutic target in heart failure with preserved ejection fraction (Q27024279) (← links)
- Left Ventricular T-Cell Recruitment Contributes to the Pathogenesis of Heart Failure. (Q27340146) (← links)
- Cardiometabolic Syndrome and Increased Risk of Heart Failure (Q28070075) (← links)
- Clinical Phenotypes in Heart Failure With Preserved Ejection Fraction (Q28073079) (← links)
- What can we learn about treating heart failure from the heart's response to acute exercise? Focus on the coronary microcirculation (Q28083350) (← links)
- Pathophysiological role of oxidative stress in systolic and diastolic heart failure and its therapeutic implications (Q28085102) (← links)
- Challenges in acute heart failure clinical management: optimizing care despite incomplete evidence and imperfect drugs (Q28085736) (← links)
- Epidemiology of heart failure with preserved ejection fraction (Q30234501) (← links)
- Impact of dietary nitrate on age-related diastolic dysfunction (Q30276909) (← links)
- Medial vascular calcification revisited: review and perspectives (Q30409314) (← links)
- Prevalence of unrecognized heart failure in older persons with shortness of breath on exertion (Q30486992) (← links)
- Cardiovascular Disease in Women: Clinical Perspectives (Q30743765) (← links)
- Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data (Q30961976) (← links)
- Risk factors for heart failure are associated with alterations of the LV end-diastolic pressure-volume relationship in non-heart failure individuals: data from a large-scale, population-based cohort (Q31071475) (← links)
- Association between cardiovascular vs. non-cardiovascular co-morbidities and outcomes in heart failure with preserved ejection fraction (Q33164540) (← links)
- The paradox of bardoxolone methyl: a call for every witness on the stand? (Q33358784) (← links)
- Advances in the pathophysiology and treatment of heart failure with preserved ejection fraction (Q33565707) (← links)
- Shared biomarkers between female diastolic heart failure and pre-eclampsia: a systematic review and meta-analysis (Q33577443) (← links)
- Age, left atrial dimension and arterial stiffness after external cardioversion of atrial fibrillation. A vascular component in arrhythmia maintenance? Results from a preliminary study (Q33624268) (← links)
- Developing therapies for heart failure with preserved ejection fraction: current state and future directions (Q33639223) (← links)
- Update on heart failure with preserved ejection fraction (Q33640339) (← links)
- Circulating levels of tumor necrosis factor-alpha receptor 2 are increased in heart failure with preserved ejection fraction relative to heart failure with reduced ejection fraction: evidence for a divergence in pathophysiology (Q33748856) (← links)
- Zinc Finger E-Box Binding Protein 2 (ZEB2) Suppress Apoptosis of Vascular Endothelial Cells Induced by High Glucose Through Mitogen-Activated Protein Kinases (MAPK) Pathway Activation (Q33764076) (← links)
- Excess Cardiovascular Risk in Women Relative to Men Referred for Coronary Angiography Is Associated With Severely Impaired Coronary Flow Reserve, Not Obstructive Disease (Q33765268) (← links)
- Phenotypic spectrum of heart failure with preserved ejection fraction (Q33827302) (← links)
- Targeting Endothelial Function to Treat Heart Failure with Preserved Ejection Fraction: The Promise of Exercise Training. (Q33863759) (← links)
- Heart failure with preserved ejection fraction: molecular pathways of the aging myocardium (Q33889242) (← links)
- Metabolic Dysfunction in Heart Failure: Diagnostic, Prognostic, and Pathophysiologic Insights From Metabolomic Profiling (Q33892283) (← links)
- Dipeptidyl peptidase inhibition prevents diastolic dysfunction and reduces myocardial fibrosis in a mouse model of Western diet induced obesity (Q34027687) (← links)